Oran Rigby

CEO

Akkure Genomics

Dublin, Ireland

14 profile visitsStartup/Scaleup representative (MATCH.POINT)

Professor Rigby, a Churchill scholar, is an Executive medical director, digital health entrepreneur & medical ICU specialist, along with A/Prof of AI systems.

My organisation

Akkure Genomics

Startup / Scaleup

Dublin, Ireland

AKKURE revolutionizes the Pharmaceutical & Hospital industry with a patient-centric platform for smart contract based dynamic consent management of patient’s clinical, genomic and physiological data, creating new assets from public & enterprise data transformed into digital medical twins (DMTs) for continuous real-time access to integrated patient data. DMTs for pre-clinical Insilico trial models, offer live insights for patient identification, cohort localisation and global site consolidation, incorporating digital and multiomic biomarkers accelerating virtual and precision oncology trials. Developed in stealth with Microsoft, validated via a commercial pilot focused on breast cancer with a leading EU medical software company accessing 500,000 patient records, endorsed through a multi-year partnership with a top 3 global CRO, and accelerated with a POC with the world's largest EMR provider & hospital network in a nation creating 1 million digital twins, AKKURE is active with EMR and health data providers over 4 continents. Key pharmaceutical customers, including the aforementioned CRO, show readiness to adopt our innovative approach for securing RWE/RWD access and DMT powered Insilico precision trial matching. Embracing opportunities for patient-owned health data democratization and secondary use and access via the US 21st Century Cures Act and EU's 2024 Health Data Space legislation, AKKURE transforms new and existing health data into a foundational digital infrastructure for a global precision trials/therapeutics market.

About me

Professor Rigby, a Churchill scholar, is an Executive medical director, digital health entrepreneur and senior medical Intensivist sub-specialising in neuro-intensive care, with Australian and European postgraduate qualifications in Surgery, Aeromedicine, Tropical medicine & International health.

His Churchill fellowship was awarded to support clinical translational research into innovative business models and applications for virtual care and networked Telemedicine in remote trauma, neuro and cardiac critical care. His MPH from the University of Piemonte focused on surge capacity in ICU during pandemic & disaster responses.
A further fellowship at Harvard business school was awarded focusing on innovations in shared value for healthcare.

He was engaged as the senior medical consultant advising the Royal Flying Doctor Service on redesign and digital transformation of their medical services & function for the 21st century through the company CRITeCARE of which he was CEO.

His previous roles as NSW state clinical director for trauma services at over 200 hospitals & Executive Medical Director for Oneview Healthcare, an ASX listed provider of patient engagement, allowed for the practical application of his vision for digital health transformation.

A serial Tech entrepreneur & investor in areas as diverse as medical drones, medical social media & global medical virtual care solutions & marketplaces.
He has founded multiple digital health startups including PLEXA.ai, AKKURE Genomics, CRITeCARE, DOCNOSTICS & Medetourism and successfully raised multiple millions in investment.

A clinical researcher in multiple trials, he fuses his medical expertise with a passion for technology and its futuristic novel application. An honorary consultancy in Neuro-intensive care at Cambridge University Hospital facilitated his third masters thesis (MSc trauma surgery & MSc Orthopaedic medicine) exploring poly-compartment syndrome & Traumatic brain injury.
He was senior medical director/ co-ordinator with the NSW aeromedical & counter disaster service until 2016 occupying both strategic & tactical roles.

Winner of the UCD Molloy prize for Applied Physics 1993.

As both Associate Professor with the Q.U.T. department of Robotics & autonomous systems and as a visiting scholar at Harvard University with the Harvard Humanitarian Initiative, he offers insights into leveraging frontier tech in the medical environment.